These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12088781)

  • 21. Determination of a weight-adjusted dose of TNK-tissue plasminogen activator.
    Wang-Clow F; Fox NL; Cannon CP; Gibson CM; Berioli S; Bluhmki E; Danays T; Braunwald E; Van De Werf F; Stump DC
    Am Heart J; 2001 Jan; 141(1):33-40. PubMed ID: 11136484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Think Twice Before Using This Abbreviation.
    Paparella SF
    J Emerg Nurs; 2019 Jan; 45(1):85-87. PubMed ID: 30616768
    [No Abstract]   [Full Text] [Related]  

  • 23. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.
    Ohman EM; Van de Werf F; Antman EM; Califf RM; de Lemos JA; Gibson CM; Oliverio RL; Harrelson L; McCabe C; DiBattiste P; Braunwald E;
    Am Heart J; 2005 Jul; 150(1):79-88. PubMed ID: 16084152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment.
    Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demanding times.
    Lipley N
    Emerg Nurse; 2002 Nov; 10(7):5. PubMed ID: 12476669
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombolysis medication errors: benefits of bolus thrombolytic agents.
    Cannon CP
    Am J Cardiol; 2000 Apr; 85(8A):17C-22C. PubMed ID: 10793176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase for treatment of acute myocardial infarction.
    Turcasso NM; Nappi JM
    Ann Pharmacother; 2001 Oct; 35(10):1233-40. PubMed ID: 11675853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism.
    Becattini C; Agnelli G; Salvi A; Grifoni S; Pancaldi LG; Enea I; Balsemin F; Campanini M; Ghirarduzzi A; Casazza F;
    Thromb Res; 2010 Mar; 125(3):e82-6. PubMed ID: 19833379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing medication errors: potential benefits of bolus thrombolytic agents.
    Richards CF; Cannon CP
    Acad Emerg Med; 2000 Nov; 7(11):1285-9. PubMed ID: 11073480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leading the Way by Adopting Safe Medication Practices Associated With Abbreviation Use.
    Zrelak PA
    J Neurosci Nurs; 2018 Jun; 50(3):121-122. PubMed ID: 29727389
    [No Abstract]   [Full Text] [Related]  

  • 31. The thrombolysis in myocardial infarction (TIMI) trial.
    Ganz W
    N Engl J Med; 1985 Oct; 313(16):1018. PubMed ID: 3930960
    [No Abstract]   [Full Text] [Related]  

  • 32. Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction.
    McGahan L
    Issues Emerg Health Technol; 2001 Jan; (13):1-6. PubMed ID: 11902221
    [No Abstract]   [Full Text] [Related]  

  • 33. Tenecteplase: a promising new fibrinolytic agent.
    De Jong MJ; Sabadie-Garretson W
    Dimens Crit Care Nurs; 2001; 20(6):19-23. PubMed ID: 22076580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction.
    Huisse MG; Ajzenberg N; Feldman L; Guillin MC; Steg PG
    Thromb Haemost; 2009 Apr; 101(4):734-40. PubMed ID: 19350119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarction.
    Tranchesi B; Bellotti G; Chamone DF; Verstraete M
    Am J Cardiol; 1989 Jul; 64(3):229-32. PubMed ID: 2500842
    [No Abstract]   [Full Text] [Related]  

  • 36. Tenecteplase and alteplase in acute myocardial infarction.
    Norris RM
    Lancet; 1999 Nov; 354(9192):1818-9. PubMed ID: 10577663
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.
    Gibson CM; Cannon CP; Murphy SA; Marble SJ; Barron HV; Braunwald E;
    Circulation; 2002 Apr; 105(16):1909-13. PubMed ID: 11997276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body weight, not thrombus-burden tissue plasminogen activator dosing: but still.
    Alexandrov AV; Tsivgoulis G
    Stroke; 2010 Dec; 41(12):2723-4. PubMed ID: 21071721
    [No Abstract]   [Full Text] [Related]  

  • 39. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
    Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tenecteplase in acute cerebral infarction].
    Kvistad CE; Thomassen L; Aamodt AH; Logallo N
    Tidsskr Nor Laegeforen; 2018 Jan; 138(1):. PubMed ID: 29313604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.